It is known that normal epithelial cells and epithelial tumor cells are different in the glycoprotein pattern of their outer cell membrane and there are some differences in the structure of the mucin between normal cells and tumor cells; therefore, transmembrane glycoprotein Mucin 1 (MUC1) is considered a potential target for cancer therapy [112]. The gene discussed is MUC1; the disease is neoplasm.